This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sun, X.-M. Articles by Soutar, A.K. Search for Related Content PubMed PubMed Citation Articles by Sun, X.-M. Articles by Soutar, A.K.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:219-227.)
© 1995 American Heart Association, Inc.

Articles

Characterization of a Splice-Site Mutation in the Gene for the LDL Receptor Associated With an Unpredictably Severe Clinical Phenotype in English Patients With Heterozygous FH

X.-M. Sun; D.D. Patel; D. Bhatnagar; B.L. Knight; A.K. Soutar

From the Lipoprotein Team, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London, and the Department of Medicine, The Royal Infirmary, Manchester (D.B.), England.

Correspondence to Dr A.K. Soutar, Lipoprotein Team, MRC Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 ONN.

Abstract We have identified a substitution of G to A in the first base pair of intron 3 in the LDL receptor gene of an English heterozygous familial hypercholesterolemia (FH) patient. Reverse transcription, amplification, and nucleotide sequencing of the LDL receptor mRNA from mononuclear blood cells showed both the normal mRNA and one that lacked the nucleotides encoded by exon 3, which codes for repeat 2 of the ligand-binding domain. The same mutant allele was identified in 2/200 unrelated FH patients from the London area and 4/77 from Manchester. Immunoblotting of cultured lymphoblasts from the index patient revealed the normal receptor protein and smaller amounts of a receptor protein with electrophoretic mobility consistent with a deletion of the 41 amino acid residues encoded by exon 3. Normal amounts of a similar protein were observed when the mutant cDNA was expressed in heterologous cells; this protein showed reduced binding affinity for LDL but bound apoprotein E–containing lipoproteins normally. Despite these and other observations that repeat 2 of the binding domain is relatively unimportant for receptor function in vitro, carriers of this allele exhibit a severe clinical phenotype, typical of FH. Thus, the relationship between genotype and phenotype in heterozygous FH is not always predictable.

Key Words: mutant protein • immunoblotting • LDL binding • single-strand conformational polymorphism • in vitro expression

This article has been cited by other articles:

				M. Junyent, R. Gilabert, D. Zambon, M. Pocovi, M. Mallen, M. Cofan, I. Nunez, F. Civeira, D. Tejedor, and E. Ros Femoral Atherosclerosis In Heterozygous Familial Hypercholesterolemia: Influence Of The Genetic Defect Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 580 - 586. [Abstract] [Full Text] [PDF]

				S E Humphries, R A Whittall, C S Hubbart, S Maplebeck, J A Cooper, A K Soutar, R Naoumova, G R Thompson, M Seed, P N Durrington, et al. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk J. Med. Genet., December 1, 2006; 43(12): 943 - 949. [Abstract] [Full Text] [PDF]

				R. P. Naoumova, I. Tosi, D. Patel, C. Neuwirth, S. D. Horswell, A. D. Marais, C. van Heyningen, and A. K. Soutar Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene: Long-Term Follow-Up and Treatment Response Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2654 - 2660. [Abstract] [Full Text] [PDF]

				K. K. Alharbi, M. A. Aldahmesh, E. Spanakis, L. Haddad, R. A. Whittall, X.-h. Chen, H. Rassoulian, M. J. Smith, J. Sillibourne, N. J. Ball, et al. Mutation scanning by meltMADGE: Validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population Genome Res., July 1, 2005; 15(7): 967 - 977. [Abstract] [Full Text] [PDF]

				M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429. [Abstract] [Full Text] [PDF]

				J. J. Burden, X.-M. Sun, A. B. G. Garcia, and A. K. Soutar Sorting Motifs in the Intracellular Domain of the Low Density Lipoprotein Receptor Interact with a Novel Domain of Sorting Nexin-17 J. Biol. Chem., April 16, 2004; 279(16): 16237 - 16245. [Abstract] [Full Text] [PDF]

				J.-H. Chang, J.-P. Pan, D.-Y. Tai, A.-C. Huang, P.-H. Li, H.-L. Ho, H.-L. Hsieh, S.-C. Chou, W.-L. Lin, E. Lo, et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese J. Lipid Res., October 1, 2003; 44(10): 1850 - 1858. [Abstract] [Full Text] [PDF]

				X.-M. Sun and A. K. Soutar The Transmembrane Domain and PXXP Motifs of ApoE Receptor 2 Exclude It from Carrying out Clathrin-mediated Endocytosis J. Biol. Chem., May 23, 2003; 278(22): 19926 - 19932. [Abstract] [Full Text] [PDF]

				M. A.W. Umans-Eckenhausen, E. J.G. Sijbrands, J. J.P. Kastelein, and J. C. Defesche Low-Density Lipoprotein Receptor Gene Mutations and Cardiovascular Risk in a Large Genetic Cascade Screening Population Circulation, December 10, 2002; 106(24): 3031 - 3036. [Abstract] [Full Text] [PDF]

				R A Whittall, S Matheus, T Cranston, G J Miller, and S E Humphries The intron 14 2140+5G>A variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels J. Med. Genet., September 1, 2002; 39(9): e57 - 57. [Full Text] [PDF]

				R. Thiart, C. L Scholtz, J. Vergotine, C. F Hoogendijk, J N. P de Villiers, H. Nissen, K. Brusgaard, D. Gaffney, M. S Hoffs, W J H. Vermaak, et al. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia J. Med. Genet., July 1, 2000; 37(7): 514 - 519. [Abstract] [Full Text]

				L. Deiana, R. Garuti, G. M. Pes, C. Carru, A. Errigo, M. Rolleri, L. Pisciotta, P. Masturzo, A. Cantafora, S. Calandra, et al. Influence of {beta}0-Thalassemia on the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia : A Study of Patients With Familial Hypercholesterolemia From Sardinia Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 236 - 243. [Abstract] [Full Text] [PDF]

				S. H. Kim, J. H. Bae, J. J. Chae, U. K. Kim, S.-J. Choe, Y. Namkoong, H.-S. Kim, Y.-B. Park, and C. C. Lee Long-Distance PCR-based Screening for Large Rearrangements of the LDL Receptor Gene in Korean Patients with Familial Hypercholesterolemia Clin. Chem., September 1, 1999; 45(9): 1424 - 1430. [Abstract] [Full Text] [PDF]

				Y. von Kodolitsch, R. E. Pyeritz, and P. K. Rogan Splice-Site Mutations in Atherosclerosis Candidate Genes : Relating Individual Information to Phenotype Circulation, August 17, 1999; 100(7): 693 - 699. [Abstract] [Full Text] [PDF]

				S. Bertolini, S. Cassanelli, R. Garuti, M. Ghisellini, M. L. Simone, M. Rolleri, P. Masturzo, and S. Calandra Analysis of LDL Receptor Gene Mutations in Italian Patients With Homozygous Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 408 - 418. [Abstract] [Full Text] [PDF]

				X.-M. Sun, D. D. Patel, B. L. Knight, and A. K. Soutar Comparison of the Genetic Defect with LDL-Receptor Activity in Cultured Cells from Patients With a Clinical Diagnosis of Heterozygous Familial Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3092 - 3101. [Abstract] [Full Text]